<SEC-DOCUMENT>0000939767-18-000110-index.html : 20180524
<SEC-HEADER>0000939767-18-000110.hdr.sgml : 20180524
<ACCEPTANCE-DATETIME>20180524203034
ACCESSION NUMBER:		0000939767-18-000110
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20180524
FILED AS OF DATE:		20180524
DATE AS OF CHANGE:		20180524

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Smith Julie
		CENTRAL INDEX KEY:			0001557928

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30235
		FILM NUMBER:		18859454

	MAIL ADDRESS:	
		STREET 1:		C/O RAPTOR PHARMACEUTICAL CORP
		STREET 2:		9 COMMERCIAL BLVD, SUITE 200
		CITY:			NOVATO
		STATE:			CA
		ZIP:			94949

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			EXELIXIS, INC.
		CENTRAL INDEX KEY:			0000939767
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				043257395
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0102

	BUSINESS ADDRESS:	
		STREET 1:		210 E. GRAND AVE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		6508377000

	MAIL ADDRESS:	
		STREET 1:		210 E. GRAND AVE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EXELIXIS INC
		DATE OF NAME CHANGE:	20000207

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EXELIXIS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	20000106
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>wf-form4_152720822079492.xml
<DESCRIPTION>FORM 4
<TEXT>
Document 1 - file: wf-form4_152720822079492.html

Document 1 - RAW XML: wf-form4_152720822079492.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>ex-24.htm
<DESCRIPTION>POA_DEC 2017_SMITH
<TEXT>
Document 2 - file: ex-24.htm

</DOCUMENT>
</SEC-DOCUMENT>